the Pet Cloning Industry

In the United States, the pet cloning industry has traditionally included two purchases: (1) preservation of the pet's cells/tissues for later use; and (2) the actual pet cloning procedure. The first purchase keeps the option for pet cloning open while the owner decides when the time is right.

ViaGen Pets is the only US-based company that offers pet cloning. ViaGen started in Austin, Texas, in 2002, originally offering genetic preservation and cloning for cattle, horses, and pigs. It wasn't until 2015 that it launched ViaGen Pets, the company best known for cloning dogs, cats, and horses for Americans in today's world. In 2025, ViaGen was acquired by Colossal Biosciences, the US's leader in cloning technology.

ViaGen Pets charges $50,000 for their dog/cat pet cloning procedure. Additionally, they charge $1,600 for genetic preservation, with a $150 annual storage fee.

While ViaGen Pets is the only US-based pet cloning company, there are other American companies that will bank cells for further use, such as PerPETuate.

Prior to the launch of ViaGen pets, other American companies existed that were capable of cloning pets, such as Genetic Savings & Clone (originally a project to clone a dog named Missy), though these businesses were not commercially viable. In 2004, Genetic Savings & Clone delivered Little Nicky, a cloned dog, to a woman in Texas for $50,000.

Following the closure of Genetic Savings & Clone in 2006, Americans would need to look overseas, typically with companies in South Korea, such as RNL Bio or Sooam Biotech Research Foundation (contracted through BioArts International).

In 2026, pet cloning is a spectacle for the public eye. Celebrities such as Barbra Streisand and Tom Brady have cloned their pets, drawing more attention from the public.